NCT00360230 Partially-blind (Observer-blind) Study of Safety and Immunogenicity of Two Malaria Vaccines in Ghanaian Children Status COMPLETED Phase PHASE2
NCT00355225 Community-Effectiveness of the Distribution of Insecticide-Treated Bed Nets Through Social Marketing Antenatal Care Services in Malaria Control in Rural Burkina Faso Status COMPLETED Phase NA
NCT00354380 Safety and Efficacy of Methylene Blue Combined With Artesunate or Amodiaquine for Malaria Treatment in Children of Burkina Faso: a Pilot Study Status COMPLETED Phase PHASE2
NCT00351013 The Use of Homeopathic-Based Treatment Approaches to Reduce the Prevalence of Malaria in Depressed Communities Status COMPLETED Phase PHASE4
NCT00349713 FMP2.1/AS02A: Rabies Vaccine Malaria-Experienced Adults in Bandiagara, Mali Status COMPLETED Phase PHASE1
NCT00347113 Schistosome and Intestinal Worm Infections and Malaria Morbidity Among School and Pre-school Children in, Tanzania Status COMPLETED Phase NA
NCT00346346 Analysis of the Immune Response to the Malaria Parasite in Mali, West Africa Status COMPLETED Phase N/A
NCT00341783 Assessment of Biologic Parameters in Preparation for Future Malaria Vaccine Trials in Don gu Bougou, Mali Status TERMINATED Phase N/A
NCT00341666 Immune Response Regulation in People Infected Concurrently With Malarial and Filarial Parasites Status COMPLETED Phase N/A
NCT00336388 Use of Rapid Diagnostic Tests for Malaria Case Management in Kenya Status COMPLETED Phase NA
NCT00336375 Treatment of Uncomplicated Childhood Malaria in Tanzania by Artemether+Lumefantrine - Efficacy and Genotyping Status COMPLETED Phase PHASE4
NCT00331708 Artesunate Plus Sulfadoxine-pyrimethamine Pharmacokinetics, Efficacy, Gametocytes Carriage and Birth Outcomes in Pregnant Women With Malaria Status TERMINATED Phase NA
NCT00329134 Investigation of the Efficacy of Quinine Sulphate Administered Via Taste-Masked Pellets to Children With Falciparum Malaria Status COMPLETED Phase PHASE2
NCT00323622 Long-Term Follow-up of Children for a 2-Year Period to Confirm the Safety and Immunogenicity of GSK 257049 Vaccine Status COMPLETED Phase PHASE2
NCT00323375 Studies of AQ-13, a Candidate Aminoquinoline Antimalarial, in Comparison With Chloroquine Status COMPLETED Phase PHASE1